Found 0 matching trials
A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS PHASE1 Alvocidib, a cyclin-dependent kinase 9 (CDK 9) inhibitor, in time-sequentia...
Show More Location
University of Chicago
Learn More & Join Trial
Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) PHASE2 The purpose of this study is to determine the safety and effectiveness of p...
Show More Location
City of Hope Comprehensive Cancer Ctr
Learn More & Join Trial
Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma PHASE1 RATIONALE: Drugs used in chemotherapy, such as azacitidine and dexamethason...
Show More Location
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Learn More & Join Trial
A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia PHASE2 The study aim is to compare safety and efficacy of high-dose lenalidomide r...
Show More Location
(210) University of Arizona Cancer Center
Learn More & Join Trial
Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) PHASE2 The purpose of the study is to determine how effective azacitidine, MGCD010...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome PHASE2 The purpose of the study is to determine whether azacitidine is safe and ef...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia PHASE3 This study is a multicenter, randomized, open-label, phase III clinical stu...
Show More Location
Anhui Provincial Hospital(The First Affiliated Hospital of U STC)
Learn More & Join Trial
Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome PHASE1 This is a phase I study with a primary objective of determining the recomme...
Show More Location
Froedtert Hospital & the Medical College of Wisconsin
Learn More & Join Trial
A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation (ALIVE) PHASE3 The purpose of this study is to determine the clinical benefit of XY0206 th...
Show More Location
Multiple Locations
Learn More & Join Trial
A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care PHASE3 The purpose of this study is to determine whether patients with high-risk m...
Show More Location
University of Alabama School of Medicine
Learn More & Join Trial